Modern cancer care for the next billion people Hedera Dx enables health systems, patients and drug development programs to easily adopt advanced molecular testing and real-world evidence (RWE) capabilities. Join us on hederadx.com to learn more! Oncology, Next-Generation Sequencing, Liquid Biopsy, ctDNA, IVDR Compliance, Medical Device, Precision Medicine, and RWE

164 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

423 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Late clinical stage company focused on drug discovery and development for the treatments of rare disorders of the CNS For additional information: info@sombiotech.com Pre-clinical validation, Licensing, In silico screening, Rare Diseases, Drug repurposing, Orphan CNS indications, Central Nervous System, Intellectual Property, and Artificial Intelligence

288 similar entities Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology

Improving health and life for people living with diabetes, obesity and other cardiometabolic diseases Arecor is a clinical-stage biotech company, developing superior therapeutics that can reduce treatment burden and improve outcomes for people living with diabetes, obesity and other cardiometabolic diseases. Superior Products for Diabetes Treatment, Liquid Products with Superior Stability, Lyo-to-liquid switch, IV to SC switch, High Concentration mAbs, Ready-to-Use (RTU) Formats, Differentiated Biosimilars, Vaccine Stability, and Oral Delivery of Peptides

206 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Global Service Partner for Pharma Inceptua Group - Helping Pharma. Helping Patients. Inceptua is a global pharmaceutical services company with market-leading capabilities across multiple business areas. - Inceptua Clinical Trial Supply and Clinical Services provides clinical trial supply, services and logistics, including comparator sourcing of medicines, packaging, labelling, storage, and distribution services. - Inceptua Early Access offers strategic advice, design, facilitation, and implementation of global early access programs, and distributes unlicensed and other medicines worldwide. Inceptua has over 25 years of experience serving life science companies of various sizes, and has global operations with offices across Europe, North America and …

57 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Data Analytics

Both a consulting firm and a training organization, Aspe Conseil offers advice and services in regulatory affairs and quality to companies operating in the fields of medicines, medical devices, food supplements and cosmetic products. Medical Devices, Medicines, Cosmetics, Dietary Supplements, and Regulatory Affairs

293 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Let's Build Better Cells Together At MaxCyte®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQureTM gene editing risk assessment services enable high-performance cell engineering and rigorous evaluation of editing outcomes, supporting confidence in therapeutic development. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we’ve been advancing cell engineering, shaping …

334 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The world leader in protein separation using innovative electrophoresis systems Sebia France is a subsidiary of the Sebia Group. Founded in 1967, Sebia is a global player specializing in in vitro diagnostics for the screening and monitoring of various diseases, mainly in the areas of oncology (multiple myeloma), diabetes, hemoglobinopathy, autoimmunity and other rare pathologies. Sebia's mission is to provide powerful tools that translate what is happening in a patient's body into readable and interpretable language. We call it our new language of life. Headquartered in South Paris (Lisses, France), we have set strict standards for achieving continuous advancements in …

64 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Created in 2013, CleveXel Pharma is a pharmaceutical company with an innovative business model based on maximizing the marketing potential of disruptive molecules in exchange for a stake in the partner's equity or for the gradual purchase of a license. LIFE SCIENCES, PHARMACEUTICAL DEVELOPMENT, CLINICAL RESEARCH, and QUALITY / COMPLIANCE

92 similar entities Type: Startup Activities: biotech deeptech martech

Power Your Health Di&Care is a French company dedicated to the development and marketing of “digital medicines” in the field of sleep and mental health. Our treatments are based on reference therapies in the management of these diseases. health, mental health, digital medicines, healthcare professionals, sleep specialists, IUD Sleep, and Doctors of Pharmacy

214 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Innovative medicines to address haemato-oncology related life-threatening and rare diseases ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases. Following strategic acquisitions and targeted developments, ElsaLys is establishing an immunotherapeutic portfolio focused on niche specialty pharmaceuticals to answer unmet medical needs. Our commitment is to offer essential drugs meeting Public Health needs. Founded in 2013, ElsaLys Biotech is located in the heart of the European cluster Lyon Biopole, in Lyon, France. Anticorps thérapeutiques, Anticorps monoclonaux, Therapeutic antibodies, Monoclonal antibodies, ophtalmologie, immune microenvironment, vascular …

86 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Reinvent the traceability of implantable medical devices to democratize and simplify clinical follow-up Our mission: Build secured and protected global Medical Device Health Registry by collecting data at the point of use in the Operating Room for practicing evidence-based medicine and tracing implantable devices to protect patient safety and meet regulatory compliance. Traçabilité, Santé, Prothèses, Dispositifs médicaux, Implants, DMI, IUD, DM, Wiki, Bloc opératoire, GS1, UDI, and Wiki

346 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Regenerative Medicine - Growth Disregulation - Oncology REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its …

140 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology

A wholly owned subsidiary of Eli Lilly and Company. Centessa Pharmaceuticals plc, a wholly owned subsidiary of Eli Lilly and Company, is developing a portfolio of orexin receptor 2 (OX2R) agonists for the potential treatment of sleep-wake and other neuroscience disorders.

59 similar entities Type: SMB Activities: biotech deeptech

Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in …

199 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

NEW FRONTIERS IN NEUROSCIENCE Neurentis PLC is a late-clinical stage UK specialty pharma company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with an advanced lead drug for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development as well as earlier stage drug candidates in collaboration with research institutions and other companies. The company is run by experienced ex-pharma industry executives, with more than 35 years’ experience in the sector each. The company’s low-risk commercial strategy is to commercialize …

382 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Aesyra SA is a spin-off of EPFL created in November 2017 in close collaboration with medical experts from the Clinique Universitaire de Médecine Dentaire de Genève (CUMD). Aesyra’s mission is to develop, manufacture and commercialize a medical device able to accurately monitor the jaw activity of the patient during sleep and provide an active bio-feedback to reduce teeth grinding without waking-up the patient.

69 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Pioneering a new era in precision medicine for women's health A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health. ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare

301 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology A.I.

Improved Diagnosis for Life Olea Medical, a provider of advanced MR and CT perfusion imaging post-processing, designs medical imaging applications improving diagnostic processes. Olea Medical was incorporated in 2008, but its history began in 1998, when its founder, then a young medical school student, decided to transition to computer engineering. A trick of life plunged him into the world of medical research to design software dedicated to the processing of medical images for hyper acute stroke – the ancestor of PerfScape and NeuroScape. After a ten-year career in military informatics, the idea of Olea Medical emerged with three other engineers, …

56 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: SaaS

Bringing reliability and expertise to clinical development. Aixial Group is a specialized clinical development partner with the commitment, expertise, and flexibility needed to deliver efficient clinical trials. Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform. For more information, please visit: aixialgroup.com Service Delivery Models: • End to End Clinical Trial Services • Functional Service Provider (FSP) Model • Business Process Outsourcing (BPO) Model • Expert Consulting & Advice • Resourcing & Staffing Biometrics and Clinical Research, Contract Research Organisation, biostatistics, data-management, E-CRF, medical …

57 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

CRO indépendante full service depuis 1986 | Essais cliniques, Accès précoce, Home Trial | France & Europe 🇬🇧 Since 1986, Euraxi has been supporting healthcare industry clients in the design and delivery of their clinical research projects. As an independent full-service CRO, we have managed over 1,000 clinical trials, covering the full development cycle: Phase I-IV clinical trials, non-interventional studies, early access & compassionate use programs, Home Trial Services (national nurse network), medical devices and Market Access. Our specialised multidisciplinary teams adapt 100% to your needs, in France and across Europe. 📩 Contact us: www.euraxi.fr Monitoring, Project management, Data-management (10 …

152 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and …

65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

349 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

519 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune

565 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free

83 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology

337 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We help life sciences companies manage clinical, quality, and regulatory processes so they can focus on improving lives With offices in the US, Europe, Japan and Japan, Agatha is dedicated to helping the world’s Hospitals, biotechnology, pharmaceutical, contract research organizations and medical device firms optimize the management of their Quality, Regulatory and Clinical documentation and processes. With lower costs and faster on-boarding, Agatha delivers the best ROI on business applications for life sciences that are ready to use and easy to adopt. Agatha, Inc. is a strategic software solution provider to the healthcare and life sciences industry, providing SaaS-based business …

58 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

The Euro/Global Platform for Drug Repurposing REPO4EU is the Euro/Global Platform for Drug Repurposing - from imprecise drug therapy to AI-powered precision medicine. Should you need any help in searching for bioinformatics support for an unmet medical need, a registered compound or a specific mechanism; exploring your freedom to operate or a patenting strategy or regulatory advice; liaising with a business partner, setting up a clinical trial test site for phase I-III or crafting a business plan... we have the experts and global experience to help and work with you! bioinformatics, drug repurposing, artificial intelligence, and pharmacology

214 similar entities Type: Startup Activities: biotech Technologies: SaaS

The reference for health products Act on prevention, optimize and secure your prescriptions, improve patient care. electronic drug database, artificial intelligence, prevention, diagnostic assistance, and patient care

161 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Expanding the reach of highly potent cancer therapies with the pre|CISION® platform. Avacta is a clinical stage biotechnology company expanding the reach of highly potent cancer therapies with the pre|CISION® platform. Custom antibody alternative, Antibody alternatives, and Afinnity reagents

95 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

616 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

514 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Advancing Medecine Together Creapharm is now Myonex - Myonex is an industry leader in global clinical trial supply and pharmaceutical commercial services. Our suite of integrable services and solutions helps pharmaceutical, biotech, and CRO partners advance medicine by reducing time, costs, and complexity. With locations in the US, Germany, UK, and France, our comprehensive, client-focused approach, coupled with expert project management, ensures seamless execution across regions, optimizes supply chain efficiency, and adapts to evolving trial or project needs while delivering quality, flexibility, and global scale. Learn more at www.myonex.com. Clinical GMP Production, Clinical Packaging, Distribution Distribution, International Depot Network, IMP …

211 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies

296 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Trusted Advisor and CRO for Life Sciences Companies Globally Alira Health is a global healthcare consultancy redefining evidence generation through patient partnerships. By uniting strategic consulting, CRO services, and technology, the company supports life sciences organizations in accelerating development, improving access, and delivering measurable outcomes across the product lifecycle. Nuclear medicine, Rare disease, Robotics, CDMO medtech, Value-based contracting, Drug delivery systems, Antibody–drug conjugates, Biosimilars, CDMO medtech, CDMO biologics, Autoimmune, Wound care, and Cell&gene

157 similar entities Type: SMB Activities: biotech consulting deeptech healthtech Technologies: Data Analytics

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine

348 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Denmark-based group of companies focused on production and distribution of OTC CBD medical devices and cosmetics. CS MEDICA is a group of two fully-owned, Denmark-based subsidiaries: Galaxa Pharma A/S and CanNordic A/S, whereby CanNordic A/S is a registered Medical Device product developer and Galaxa Pharma A/S is product distributor in the Nordic Region. We see ourselves as a company in constant development, exploring the ways in which we can support patients in their battle against the disease, the pain and the sorrow it brings. Medical Device, Pharmaceuticals, Cosmetics, Regulatory Affairs, Distribution, Manufacturing, Cannabinoids, and CBD

230 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Neem’s Hill is a holding company focused on investments and innovations in the medical device sector. Through its portfolio companies, it develops and commercializes patented Tumour Specific Electroporation (TSE) technology for cancer treatment. Today, the Group operates in both Human Care and Animal Care, with the ambition to improve clinical outcomes while reducing side effects through innovative, tissue-preserving cancer treatments. Cancer Treatments, Research, Clinical Development, Chemotherapy, and Immunotherapy

307 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception. medical device, biotechnology, urology, contraception, womenshealth, reproductivehealth, and menshealth

252 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance

419 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences

214 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Delivering local-acting immunotherapies to patients ATMP, Gene Therapy, Drug development, Clinical trials, GMP, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, IBD, Cysticfibrosis, SAVI, colitis, Cystic fibrosis, and Inhalation

646 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

33 years of clinical research in pharmacy, medical device & amp; Dermo-cosmetics Quanta Medical Sharing experience Cro since 1986. 30 years of advice and operational services in clinical research and observational studies, 30 years of presence in Europe and on the African continent alongside the pharmaceutical, agro-food, dermatological, cosmetics and medical device, 30 years of human health know -how reinforced by: - a double ISO 9001 & amp; 27001 -dedicated technical tools (Quanta View®, E-CRF, Trial-on-Line®) Clinical research / Clinical trial, E-CRF, Epidemiological Study, Data Management / Biometrics, Medical Writing, Health IT development, Evaluation of health risks, and regulatory advice

467 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

A leading nationwide clinical research site network pursing life-changing therapies committed to better patient outcomes CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites’ commitment to real world solutions. Rely on us to …

131 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Transforming Energy into Therapy Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. medical device, COPD, AF, Oncology, Intervential Oncology, Intervential Pulmonology, AFib, PEF, PEF Ablation, Soft Tissue Ablation, Cardiac Arrhythmias, and Chronic Bronchitis

451 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Eurosafe is a Good Laboratory Practices (GLP) certified contract research company (CRO), specializing in human and veterinary pharmaceuticals, cosmetic products (ingredients and finished products), food supplements and medical devices. Depending on your products, a single contact, surrounded by scientists and regulatory experts, supports you to define and carry out the regulatory procedures, carry out the ADME (Absorption, Distribution, Metabolism and Elimination), safety, tolerance or effectiveness tests necessary for the marketing of your products. Eurosafe is a unique CRO with multiple skills, organized around 3 complementary areas: - In vitro tests - Tests on volunteers - Toxicological and regulatory expertise The …

56 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization

164 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Contract Research Organisation CLINACT, a MultiHealth Group company, is a Contract Research Organisation (CRO) assisting you in your health products development: pharmaceutical, medical devices, biotechnology, cosmetics, nutrition... With more than 20 years of experience, CLINACT provides its expertise for large range of innovative services: - Clinical operations - Biometrics - Medical and regulatory affairs - Pharmacovigilance, medical device vigilance and other vigilances - E-tools : Clinfile - Outsourcing and recruting : TempoPHARMA - Professional Training : FORMATIS This range of services fully covers industrials or academic organisations' requirements. As a MultiHealth company, CLINACT can also provide specific services withtout any …

76 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Trusted partner offering integrated continuum services for medicinal products to access the french market #EAP #CUP #MA - French pharmaceutical company to support global pharma to access to the frenck market - Operate as your affiliate in France combining the exploitation, the distribution, the manufacturing & importation in a single integrated continuum process - Independent and family-owned company - Part of DESTAING PARTICIPATIONS GROUP Early Access, Exploitant services, Orphan drug, Rare disease, Distribution, Promotion, Compassionate, and Market Access

237 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

The Premier Commercialization and Marketing Partner for Orphan Drugs and Rare Disease Markets Worldwide Havas Life Rare brings strategic thinking, creative solutions, and true partnership to the rare disease market. We work with companies throughout the entire lifecycle to develop commercial strategy, meaningful engagement with the patient-clinician-advocacy community, and ensure that the right therapy reaches the right patient. In a setting where natural history, diagnosis, awareness and differentiation are typically underdeveloped, we bring rigorous strategic thinking, deep medical insight, data-driven omnichannel marketing, and extensive rare disease commercial experience to navigate the right path forward.

141 similar entities Type: Startup Activities: healthtech martech Technologies: Synthetic Biology

Abzena is the leading integrated bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, …

203 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

582 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

ALIOS Conseil is a CRO created in 1995 and specialized in providing experts to the health industries (Pharmaceuticals, Medical Devices and Cosmetics) Our consulting offering is structured around our 5 departments: Clinical Research, Health Product Vigilance, Medical Affairs, Regulatory Affairs and Quality Assurance. Our goal: meet your needs and support you with your issues ALIOS CONSEIL is: - A tailor-made, fast and efficient response - Motivated, experienced employees who are monitored throughout their intervention - Transparency for our customers and for our employees Contact: Website: www.aliosconseil.com Email: aliosconseil@aliosconseil.com Tel. : 07 88 81 64 52 Provision of collaborators, Management Consulting, …

79 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide …

93 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule

634 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

miRNA-enhanced Extracellular Vesicles Therapeutics ConvEyXO, founded in 2019 by veterans of pharma industry, builds a specialized technology platform to convey exosome-based therapeutics to the market. The company is developing is therapeutic portfolio in the field of fibrosis and chronic inflammatory disorders. The rapid development of the company is the result of collaborations with partners with a demonstrated track record in healthtech and biotech fields manufacturing, process development, upstream, downstream, extracellular vesicles, exosomes, therapeutics, cargo, Loading, 4D, and exosomes

444 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Securing your vision Recornea is a clinical stage medtech ophthalmic company developing therapeutic solutions for treating diseases of the cornea, such as keratoconus, glaucoma and corneal transplants.

110 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

SmartCella is a global drug delivery company providing first-in-class delivery platforms for targeted therapies. SmartCella is a global drug delivery company providing first-in-class delivery platforms for targeted therapies, including the main technology, the FDA 510(k)-cleared Extroducer® for localized endovascular delivery to hard-to-reach organs and tissues, and a proprietary stem cell platform for the delivery of mRNA therapeutics.

71 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

about people about health Even before being a company, we are people at the service of people. Founded in 1984, ab medica is today the leading Italian company in the production and distribution of medical technologies and wearable medical devices, as well as a point of reference for #arobotic surgery and #telemedicine. The Group includes ab medica A TLC (leading company in the global telecommunications market), Medical Labs (production of medical devices for minimally invasive surgery), Pacinotti (distribution of medical devices) and ab salud (distribution of medical devices in Spain). The international network includes ab medica sas (France), ab medica …

317 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Clinical trial platform with IRT/RTSM, Patient Payments, Travel, eCOA & more—for confident decisions and calm action. Suvoda is a global clinical trial technology company, now strengthened by our merger with Greenphire. Backed by expert teams and rigorous processes, we specialize in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Together, we support sponsors, sites, and patients to manage the most urgent moments in the most urgent trials through a unified platform featuring RTSM (IRT), eCOA, eConsent, Greenphire Patient Payments, and Greenphire Travel software solutions. Clinical trial management, Interactive response technology, Subject randomization, Trial …

89 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Helping you achieve positive outcomes for your patients The world needs you at your best, so we create breakthrough solutions that help you save valuable time and restore patients' lives. Medical products and solutions, Dental and orthodontic supplies, and Health information solutions

296 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach. pharmaceutical, drug delivery, biotechnology, consumer & OTC, business development & consulting, out-licensing, in-licensing, divestments, acquisitions, global pharmaceutical market experts, marketing & sales, project management, biosimilars, medical device, and consultants

301 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Healthcare Specialist ALEA S.r.l. is an Italian company, based in Moncalieri (TO) born thanks to the thirty years of experience in the medical and healthcare sector of the founding members. There are many areas of expertise: infusion systems, consumables for hospital departments, laboratory diagnostic devices and electro-medical equipment. Alea S.r.l. is based on considerable knowledge of the European medical market and, with its specialized technicians, studies and develops innovative products and projects which are produced by leading foreign companies (including TUORen, Medcaptain and Citest), with which it maintains a fruitful collaboration and marketing in various European countries.

60 similar entities Type: SMB Activities: healthtech deeptech

A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation

142 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Precision Radiotherapy From Within BetaGlue Therapeutics is a clinical stage oncology company that has developed an advanced radiotherapy platform enabling localised targeted treatment of both unresectable solid tumours and also treatment of surgical resection margins called YntraDose. radiotherapy, nuclear medicine, oncology, and medical devices

207 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology